The increased stiffness observed in breast cancer lesions could be attributed to the changes in extracellular matrix (ECM) composition, including the increased deposition of collagen fibres, glycoproteins (fibronectin, tenascin, elastin), and/or the increased matrix crosslinking through the activity of lysyl oxidase (LOX) [70,71,72]. Here, LOX is linked to breast cancer.